Knockdown of hypoxia-inducible factor-1α in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate
- 21 April 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 342 (4), 1341-1351
- https://doi.org/10.1016/j.bbrc.2006.02.094
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patientsInternational Journal of Cancer, 2005
- Establishment and properties of fetal dermis-derived mesenchymal stem cell lines: plasticity in vitro and hematopoietic protection in vivoBone Marrow Transplantation, 2005
- Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivoBiochemical and Biophysical Research Communications, 2005
- Dynamic Balancing of the Dual Nature of HIF-1alpha for Cell SurvivalCell Cycle, 2004
- Role of Hypoxia-Inducible Factor 1 in Gastric Cancer Cell Growth, Angiogenesis, and Vessel MaturationJNCI Journal of the National Cancer Institute, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferationBiochemical and Biophysical Research Communications, 2003
- Positron Emission Tomography Scanning: Current and Future ApplicationsAnnual Review of Medicine, 2002
- Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapyGene Therapy, 2001
- A novel method for real time quantitative RT-PCR.Genome Research, 1996